KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Fulgent Genetics (FLGT) Assets Average (2016 - 2025)

Fulgent Genetics' Assets Average history spans 10 years, with the latest figure at $1.2 billion for Q4 2025.

  • For Q4 2025, Assets Average fell 1.04% year-over-year to $1.2 billion; the TTM value through Dec 2025 reached $1.2 billion, down 1.04%, while the annual FY2025 figure was $1.2 billion, 0.89% down from the prior year.
  • Assets Average for Q4 2025 was $1.2 billion at Fulgent Genetics, up from $1.2 billion in the prior quarter.
  • Across five years, Assets Average topped out at $1.5 billion in Q2 2022 and bottomed at $849.8 million in Q1 2021.
  • The 5-year median for Assets Average is $1.2 billion (2024), against an average of $1.3 billion.
  • The largest annual shift saw Assets Average soared 1006.1% in 2021 before it decreased 10.77% in 2024.
  • A 5-year view of Assets Average shows it stood at $1.2 billion in 2021, then grew by 12.42% to $1.4 billion in 2022, then dropped by 7.1% to $1.3 billion in 2023, then decreased by 5.4% to $1.2 billion in 2024, then dropped by 1.04% to $1.2 billion in 2025.
  • Per Business Quant, the three most recent readings for FLGT's Assets Average are $1.2 billion (Q4 2025), $1.2 billion (Q3 2025), and $1.2 billion (Q2 2025).